Abstract
Babesiosis (Texas fever, redwater, tick fever, etc.) was first described in 1893 by Smith and Kilborne as a tick-transmitted disease of cattle, characterized by anemia, fever, and hemoglobinuria [1]. Since then, however, it has been found that most domestic and many wild mammals are susceptible to a wide variety of Babesia species [2]. These babesias tend to be host-specific, but this is not always the case. Generally, however, the disease in a given mammalian host, referred to as babesiosis, is caused by a specific Babesia species. A list of different babesias and their major vertebrate hosts, as discussed in this review, is given in table 1. With the ever broadening scope of babesiosis in man and animal, increasing attention is being given to the development of appropriate treatment to moderate clinical signs in acutely infected individuals, to eliminate, and to prevent infection.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Smith T, Kilbourne FL: Investigations into the nature, causation and prevention of Texas or Southern cattle fever. US Dept Agriculture, Bureau of Animal Industry, Bull. No. 1, 1–301, 1893.
Purnell RE: Babesiosis in various hosts. In Babesiosis, pp. 25–63. Ristic M, Kreier JP, eds. New York: Academic Press, 1981.
Bredt AB, Weinstein WM, Cohen S: Treatment of babesiosis in asplenic patients. J Am of Med Assoc 245:1938–1939, 1981.
Brocklesby DW: Human babesiosis. J S Afr Vet Assoc 50:302–307,1979.
Skrabalo Z, Deonovic Z: Piroplasmosis in man. Report on a case. Doc Med Georgr et Trop 9:11–16, 1957.
Zaino EC, Amelkin S: Babesiosis: A potentially grave disease for the immunosuppressed. N Y State J Med 81:384, 1981.
Filstein MR, Benach JL, White DJ, Brody BA, Goldman WD, Bakal CW, Schwartz RS: Serosurvey for human babesiosis in New York. J Infect Dis 141:518–521,1980.
Anderson JF, Magnarelli LA: Canine Babesia, new to North America. Science 204:1431–1432, 1979.
Vercruysse J, Parent R: Report of an account of porcine babesiosis due to Babesiaperroncitoi in Senegal. Afrique Medicale 20 (192):435–437, 1981.
Potgieter FT: Chemotherapy of Babesia felis infection: Efficacy of certain drugs. J S Afr VetAssoc 52:289–293, 1981
Kuttler KL: Chemotherapy of babesiosis: A review. In Babesiosis, pp. 65–85. Ristic M, Kreier JP, eds. New York: Academic Press, 1981.
DeVos AJ: Epidemiology and control of bovine babesiosis in South Africa. J S Afr Vet Assoc 50:357–362, 1979.
Lewis D, Purnell RE, Francis MA, Young ER: The effect of treatment with imidocarb diproprionate on the course of Babesia divergens infections in splenectomized calves and on their subsequent immunity to homologous challenge. J Comp Path 91:285–292, 1981.
Beveridge E:Babesia rodhaini: A useful organism for the testing of drugs designed for the treatment of piroplasmosis. Ann Trop Med Parasit 47:134, 1953.
Lucas JMS: The chemotherapy of experimental babesiasis in mice and splenectomized calves. Res Vet Sci 1:218–225, 1960.
Lewis D, Williams H: Infection of the Mongolian gerbil with the cattle piroplasm, Babesia divergens. Nature 278:170. 1979.
Irvin AD, Young ER: Possible in vitro test for screening drugs for activity against Babesia and other blood protozoa. Nature 169:407–409, 1977.
Irvin AD, Young ER: Further studies on the uptake of tritiated nucleic acid precursors by Babesia spp. of cattle and mice. Int J Parasitol 9:109–114, 1979.
Erp EE, Gravely SM, Smith RD, Ristic M, Osorno BM, Carson CA: Growth of Babesia bovis in bovine erythrocyte cultures. Am J Trop Med Hyg 27:1061–1064, 1978.
Levy MG, Ristic M: Continuous cultivation in a microaerophilous stationary phase culture. Science 207:1218–1220, 1980.
Newton BA: Interaction of berenil with deoxyribonucleic acid and some characteristics of the berenil-deoxyribonucleic acid complex. Biochem J 105:50–51, 1967.
Neville DM: The interaction of acridine dyes with DNA. An x-ray diffraction and optical investigation. J Molec Biol 17:57–74, 1966.
Hebel R, Dennig HK: Licht und Elektronenmikroskopische Untersuchungen an Babesia her- pailuri nach Behandlung mit 4,4‘Diamidinodiazoamino-benzol’ (Berenil). Z Parasitenkd 33:1– 20,1969.
Simpson CF, Neal FC: Ultrastructure ofBabesia equi in ponies treated with imidocarb. Am J Vet Res 41:267–271, 1980.
Göbel E, Dennig HK: Die Ultrastruktur der Trophozoiten und Merozoiten von Babesia herpailuri in Erythrozyten der Hauskatze nach Behandlung mit Imidocarb (3,3-bis- 2-imidazolin-2-yl)-carbanilid. Z Parasitenkd 49:97–112,1976.
Joyner LP: The chemotherapy of protozoal infections of veterinary importance. J Protozool 28:17–19, 1981.
Dalgliesh RJ, Stewart NP: Tolerance to imidocarb induced experimentally in tick-transmitted Babesia argentina. Austr Vet J 53:176–180, 1977.
Theiler A: The treatment of Redwater in cattle with trypan blue. Vet J 68:64–73,1912.
Rees CW: Characteristics of the piroplasms Babesia argentina and Babesia bigemina in the United States. J Agric Res 48(5):427–438, 1934.
Legg J: The treatment of piroplasmosis (P. bigeminum) with akiron. Aust Vet J 12:227–230, 1936.
Legg J: The treatment of babesiellosis (B. argentina) with acaprin. Aust Vet J 15:121–123,1939.
Lohr FK, Otieno PS, Gacanga W: Therapy trial using betamethasone in addition to specific treatment with a diamidine and quinuronium derivate in cattle experimentally infected with Babesia bigemina. Bull Anim Hlth Prod XXIV, 199–205, 1976.
Vanzini VR, Gomez MR, Hadani A, Bermudez AC, Luciani CA, Guglielmone AA, Angold AJ: A case of intestinal torsion in a cow, apparently caused by administration of acaprin as a babesiacide. Rev Med Vet Argentina 6:503–506, 1981.
Eyre P: Some pharmacodynamic effects of the babesicidal agents quinuronium and amicar- balide. J Pharm Pharmacol 19:509–519, 1967.
Barnett SF: The chemotherapy ofBabesia bigemina infection in cattle. Res Vet Sci 6:397–415, 1965.
Purneil RE, Lewis D, Young ER: Quinuronium sulphate for the treatment of Babesia divergens infections of splenectomized calves. Vet Ree 108:538–539, 1981.
Newton LG, O’Sullivan PJ: Chemoprophylaxis in Babesia argentina infection in cattle. Aust Vet j 45:404–407, 1969.
Ryley JF: A chemoprophylactic approach to babesiasis. Res Vet Sci 5:411–418,1964.
Riek RF: Babesiosis. In Infectious Blood Diseases of Man and Animals, pp. 219–268. Weinman D, Ristic M, eds. New York: Academic Press, 1968.
Adam KMG, Blewett DA, Collins TJ, Edgar JT: Outbreaks of babesiasis on two farms in Scotland. Br Vet J 134:428–433, 1978.
Pipano E, Weisman Y, Raz A, Klinger I: Immunity toBabesia bigemina in calves after successful babesicidal treatment of a previous infection. Refuah Vet 29:1–8,1972.
Collins JD, Nuallain TO, Ferguson AR: Observations on bovine babesiosis in Ireland. Irish Vet J 24:42–51, 1970.
Pipano E, Jeruhan I, Frank M: Pentamidine in chemoimmunisation of cattle against Babesia bigemina infections. Trop Anim Hlth Prod 11:13–16, 1979.
Thompson KC, Todorovic RA, Mateus C, Adams LG: Methods to improve the health of cattle in the tropics: immunisation and chemoprophylaxis against haemoparasitic infections. Trop Anim Hlth Prod 10:75–81, 1978.
Minami T, Ishihara T:Babesia ovata sp.n. isolated from cattle in Japan. Nat I Anim Hlth O (Jpn) 20:101–113, 1980.
Todorovic RA, Vizcaino OG, Gonzalez EF, Adams LG: Chemoprophylaxis (Imidocarb)againstBabesia bigemina and Babesia argentina infections. Am J Vet Res 34:1153–1161,1973.
Callow LL, McGregor W: The effect of imidocarb against Babesia argentina and Babesia bigemina infections of cattle. Aust Vet J 46:195–200,1970.
Purnell RE, Rae MC, Deuk SM: Efficacy of imidocarb dipropionate and primaquine phosphate in the prevention of tickborne disease in imported Hereford heifers from South Korea. Trop Anim Hlth Prod 13:123–127,1981.
Taylor RJ, McHardy N: Preliminary observations on the combined use of imidocarb and Babesia blood vaccine in cattle. J S Afr Vet Assoc 50:326–329,1979.
Purnell RE, Lewis D, Young ER: Investigations on the prophylactic effect of treatment with imidocarb diproprionate on Babesia divergens infections in splenectomized calves. Brit Vet J 136:452–456, 1980.
Euzeby J, Rancien P, Simon PH: Outbreak of Babesia infection in the Charolles region of France. 3. Chemoprophylaxis by imidocarb. B Soc Sci Vet Med Comp de Lyon 76(6):423–426, 1974.
Haigh AJB, Hagan DH: Evaluation of imidocarb dihydrochloride against redwater disease in cattle in Eire. Vet Ree 94:56–69,1974.
Kuttler KL, Graham OH, Trevino JL: The effect of imidocarb treatment on Babesia in the bovine and the tick (Boophilus microplus). Res Vet Sci 18:198–200,1975.
Gray JS, Potgieter FT: The retention ofBabesia bigemina infection by Boophilus decoloratus exposed to imidocarb dipropionate during engorgement. Onderst J Vet Res 48:225–227,1981.
Mahoney DF, Mirre GB: A note on the transmission of Babesia bovis (syn. B. argentina) by the one host tick, Boophilus microplus. Res Vet Sci 26:253–254,1979.
Potgieter FT: The life cycle of Babesia bovis and Babesia bigemina in ticks and in cattle in South Africa. Ph.D. Thesis, Rand Afrikaans University, Johannesburg, S. Africa, 1977.
Day WC, Kuttler KL: Animal health considerations involved in the movement of US cattle to Haiti. SW Vet 28:229–232, 1975.
DeLoach JR, Wagner GG, Craig TM: Imidocarb dipropionate encapsulation and binding to reseal carrier bovine erythrocytes for potential babesiosis chemotherapy. J Appl Biochem 3:254–262,1981.
Kuttler KL: Use of imidocarb to control anaplasmosis. SW Vet 28:47–52,1975.
Adams LG, Corrier DE, Williams JD: A study of the toxicity of imidocarb dipropionate in cattle. Res Vet Sci 28:172–177,1980.
Aliu YO: Absorption, distribution, and excretion of imidocarb dipropionate (3,3’-bis- (2-imidazolin-2-yl)carbanilide) in sheep. Ph.D. dissertation. Texas A&M University, College of Veterinary Medicine, College Station, Texas, 1974.
Aliu YO, Davis RH, Camp B J, Kuttler KL: Absorption, distribution and excretion of imidocarb dipropionate in sheep. Am J Vet Res 38:2001–2006,1977.
Wood JC: The activity of imidocarb against Babesia infections of cattle. Irish Vet J 25:254–257, 1971.
O’Neill AR: Blood transfusions in cattle with particular reference to ‘Redwater’ (Babesiosis). Irish Vet J 33:1–7, 1979.
DeKock GDW: Drug treatment inNuttalliosis. Union of S.A., Dept of Agric 7th and 8th Reports, Dir Vet Res 639–675, April 1918.
Malhotra DV, Gautam OP, Banerjee DP: A note on chemotherapeutic trials against Babesia equi infection in donkeys. I J Anim Sc 49:75–77, 1979.
Singh B, Banerjee DP, Gautam OP: Comparative efficacy of diminazine diaceturate and imidocarb dipropionate against B. equi infections in donkeys. Vet Parasit 7:173–179,1980.
Frerichs WM, Holbrook AA: Treatment of equine piroplasmosis (B. caballi) with imidocarb dipropionate. Vet Ree 95:188–189, 1974.
Kirkham WW: The treatment of equine babesiosis. J Am Vet Med Assoc 155:457–460,1969.
Frerichs WM, Allen PC, Holbrook AA: Equine piroplasmosis (Babesia equi): Therapeutictrials of imidocarb dihydrochloride in horses and donkeys. Vet Ree 93:73–75,1973.
Adams LG: Clinicopathological aspects of imidocarb dipropionate toxicity in horses. Res Vet Sci 31:54–61, 1981.
Jansen BC: The parasiticidal effect of Aureomycin (Lederle) on Babesia equi (La Veran 1899) in splenectomized donkeys. Onderst J Vet Res 26:175–182,1953.
Dennig Von HK, Centurier C, Göbel E, Weiland G: Ein Beitrag zur Babesiose des Hundes und ihrer Bedeutung in der Bundesrepublik Deutschland und Berlin-West. Berl Münch Tierärztl Wschr 93:373–379,1980.
Moore DJ: Therapeutic implications of Babesia canis infection in dogs. J S Afr Vet Assoc 50:346–352, 1979.
Button C: Metabolic and electrolyte disturbances in acute canine babesiosis. J Am Vet Med Assoc 175:475–479, 1979.
Nuttall GHF, Hadwen S: The successful drug treatment of canine piroplasmosis, together with observations upon the effect of drugs onPiroplasma canis. Parasitol 2:156–191,1909.
Groves MG, Dennis GL: Babesia gibsoni: Field and laboratory studies of canine infections. Exp Parasit 31:153–159,1972.
Groves MG, Vanniasingham JA: Treatment of Babesia gibsoni infections with phenamidine isethionate. Vet Ree 86:8–10,1970.
Ruff MD, Fowler JL, Fernau RC, Matsuda K: Action of certain antiprotozoal compounds against Babesia gibsoni in dogs. Am J Vet Res 34:641–645,1973.
Joyner LP, Davies SFM, Kendall SB: Chemotherapy of babesiosis. In Experimental Chemotherapy, Vol. I, pp. 603–624. Schnitzer RJ, Hawking F, eds. New York, Academic Press, 1963.
Klinefelter MR: Cause, diagnosis, and treatment of canine piroplasmosis. Vet Med/SAC 77:1505–1508, 1982.
Farwell GE, LeGrand EK, Cobb CC: Clinical observations on Babesia gibsoni and Babesia canis infections in dogs. J Am Vet Med Assoc 180:507–511,1982.
Breitschwerdt EB, Malone JB, MacWilliams P, Levy MG, Quails CW, Prudish MJ: Babesiosis in the greyhound. J Am Vet Med Assoc 182:978–982,1983.
Fowler JL, Ruff MD, Fernau RC, Furusho Y: Babesia gibsoni: Chemotherapy in dogs. Am J Vet Res 33:1109–1114, 1972.
Stewart CG: A comparison of the efficacy of isometamidium, amicarbalide, and diminazene against Babesia canis in dogs and the effect on subsequent immunity. J S Afr Vet Assoc 54:47–51, 1983.
Ogunkoya AB, Adeyanju JB, Aliu YO: Experiences with the use of imizol in treating canine blood parasites in Nigeria. J Sm Anim P 22:775–777,1981.
Uilenberg G, Verdiesen PA, Zwart D: Imidocarb: A chemoprophylactic experiment with Babesia canis. Tijdschr. Diergeneesk 106:118–123, 1981.
Euzeby J, Moreau Y, Chauve C, Gevrey J, Gauthey M: Experimentation des propriétés antipiroplasmiques de l’Imidocarb sur Babesia canis, agent de la piroplasmose canine en Europe. B Aca Vet de France 53:475–480, 1980.
Coll JL, Descamps H, Fayette JP, Feraud JP, Villemin P: Essai de chimo-prevention de la Babesiose canine avec l’imidocarbe. Ree Med Vet 158:791–798,1982.
Futter GJ, Belonje PC: Studies on feline babesiosis. I. Historical Review. J S Afr Vet Assoc 50:105–106, 1980.
Stewart CG, Hackett KJW, Collett MG: An unidentified Babesia of the domestic cat (Felis domesticus). J S Afr Vet Assoc 51:219–221,1980.
Ruebush TKII, Rubin RH, Wolpow ER, Cassaday PB, Schultz MG: Neurologic complications following the treatment of human Babesia microti infection with diminazene aceturate. Am J Trop Med Hyg 28:184–189, 1979.
Entrican JH, Williams H, Cook IA, Lancaster WM, Clark JC, Joyner LP, Lewis D: Babesiosis in man: Report of a case from Scotland with observations on the infecting strain. J Infection 1:227–234,1979.
Francioli PB, Keithly JS, Jones TC, Brandstetter RD, Wolf DJ: Response of babesiosis to pentamidine therapy. Ann Int Med 94:326–330,1981.
Rowin KS, Tanowitz HB, Wittner M: Therapy of experimental babesiosis. Ann Int Med 97:556–558,1982.
Wittner M, Rowin KS, Tanowitz HB, Hobbs JF, Saltzman S, Wenz B, Hirsch R, Chisholm E, Healy GR: Successful chemotherapy of transfusion babesiosis. Ann Int Med 96:601–604,1982.
Gombert ME, Goldstein EJC, Benach JL, Tenebaum MJ, Grunwaldt E, Kaplan MH, Eveland LK: Human babesiosis, clinical and therapeutic considerations. JAMA 248:3005–3007,1982.
Michael SA, Refaii AH: The effect of imidocarb dipropionate on Babesia ovis infection in sheep. Trop Anim Hlth Prod 14:1–2, 1982.
Hashemi-Fesharki R: Studies on imidocarb dihydrochloride in experimental Babesia ovis infection in splenectomized lambs. Br Vet J 133:609–614,1977.
Lewis D, Herbert I: A large Babesia of sheep from north Wales. Vet Ree 107:352–353,1980.
Uilenberg G, Rombach MC, Perie NM, Zwart D: Blood parasites of sheep in the Netherlands. II. Babesia motasi (Sporozoa babesiidae). Vet Q 2: 3–14, 1980.
Friedhoff KT: The piroplasms of equidae-significance for international commerce. Berl Münch Tierärztl Wschr 95:368–374. 1982.
Schein E, Rehbein G, Voigt WP, Zweygarth E: Babesia equi (Laveran 1901) 1. Development in horses and in lymphocyte culture. Tropenmed P 32:223–227,1981
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Martinus Nijhoff Publishers, Dordrecht
About this chapter
Cite this chapter
Kuttler, K.L., Aliu, Y.O. (1984). Chemotherapy of babesiosis. In: Ristic, M., Ambroise-Thomas, P., Kreier, J. (eds) Malaria and Babesiosis. New Perspectives in Clinical Microbiology, vol 7. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-6042-8_11
Download citation
DOI: https://doi.org/10.1007/978-94-009-6042-8_11
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-009-6044-2
Online ISBN: 978-94-009-6042-8
eBook Packages: Springer Book Archive